Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 1 August 2026.

Announcements

1,120

Total raised

£24.3B

disclosed amounts

Series A
£58.0M

General Catalyst led the financing alongside a syndicate of new and existing investors to support the developer of antibody-based therapeutics.

"KnotBodies represent a potential breakthrough biologic drug modality, delivering greater potency, selectivity, and durability. We believe they will provide transformational new therapeutic options for ion channel- and GPCR-driven diseases across a wide range of therapeutic areas with a remaining high unmet medical need. The calibre of our international investor syndicate validates our approach, and I would like to welcome our new investors to Maxion and thank our existing investors for their continued support."
— Arndt Schottelius, Chief Executive Officer
Series A
$15.0M

West Hill Capital led the Series A+ round to support the development of atomic-scale manufacturing for space exploration.

"This funding empowers us to make atomic-scale manufacturing accessible to space agencies and research facilities worldwide. Our collaborations with NASA and ESA demonstrate our technology’s critical role in advancing space exploration. We’re enabling partners to develop previously impossible devices for space applications — from advanced materials for spacecraft to components for space-based quantum computers."
— Maksym Plakhotnyuk, Founder and CEO
Series A
£10.4M

The Series A round was led by IW Capital and will fund sales growth and product development.

"IW Capital are thrilled to announce our investment into Strolll. Strolll are transforming the physiotherapy and neurorehabilitation markets and have already helped a significant number of people with debilitating neurological disorders to live better lives. The potential impact of their software is huge and we’re proud to be backing this cutting-edge business as it addresses key healthcare needs."
— Isobel Egemole, Investment Director
Series A
£18.3M

Extantia Capital led the oversubscribed round, which will fund the construction of the company's first plant.

"We’re proving that plastic waste isn’t just a problem to solve—it’s a valuable resource waiting to be unlocked. Using the molecular precision of enzymes at an industrial scale, we’re building the solution set to make all plastics recyclable and doing so at a competitive price. This is what real circularity looks like."
— Jacob Nathan, Founder
Series A
£6.0M

The Series A round was led by Eos Ventures with participation from multiple backers to fund expansion into financial services.

"We’re thrilled to have the support of such incredible investors as we expand our vision. With Eos Ventures’ expertise in financial technology, we’re well-positioned to provide complex services delivered in a straightforward way, helping people throughout their lives."
— Ross Nichols, Co-Founder